Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A ‘New’ Human Blood Group Antigen of Frequent Occurrence

Abstract

THE sera of two women, whose babies were suspected of suffering from hæmolytic disease of the new-born, were recently found to contain identical agglutinins of a variety not previously described. The serological examination of the two families is at present incomplete, but there is so far no definite evidence in either case that the agglutinin concerned is the result of immunization of the mother by the fœtus. Indeed, the red cells of one of the jaundiced babies were not agglutinated by its mother's serum: this points towards the agglutinin being spontaneous rather than immune.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Callendar, Race and Paykoc, Brit. Med. J., ii, 83 (1945).

  2. Coombs, Mourant and Race, Lancet, i, 264 (1946).

  3. Coombs, Mourant and Race, Brit. J. Exp. Path., 26, 255 (1945).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MOURANT, A. A ‘New’ Human Blood Group Antigen of Frequent Occurrence. Nature 158, 237–238 (1946). https://doi.org/10.1038/158237c0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/158237c0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing